Healthy Yuan Haibin Pharmaceutical Co., Ltd.

To evaluate the efficacy and safety of meloxicam nanocrystal injection for postoperative analgesia in adults with laparoscopic surgery

Primary study objective (SAD): To evaluate the safety and tolerability of subjects after a single nebulized inhalation of XYP-001. Secondary study objective (SAD): To evaluate the pharmacokinetic characteristics of XYP-001 and its metabolites in subjects after a single nebulized inhalation of XYP-001. Primary study objective (MAD): To evaluate the safety and tolerability of subjects after multiple nebulized inhalations of XYP-001. Secondary study objective (MAD): To evaluate the pharmacokinetic characteristics and steady-state of XYP-001 and its metabolites in subjects after multiple nebulized inhalations of XYP-001; To evaluate the sputum peak and trough drug concentrations of XYP-001 and its metabolites in IPF subjects after nebulized inhalation of XYP-001.

To evaluate the efficacy and safety of salmeterol/fluticasone inhalation powder in the treatment of asthma in adults